<p><a href="/doc/longevity/glp/psychology/index" id="link-bibliography-_nm9Iocg-" class="prefetch-not link-page link-annotated" data-filesize-bytes="0" data-filesize-percentage="100">“‘GLP Agonist (Psych)’ Directory”</a></p>
<p><span class="date cite-date" title="2021-09-06">2021</span></p>
<p><span class="link-tags"><a href="/doc/psychiatry/alcoholism/index" class="prefetch-not link-tag link-page link-annotated icon-not" data-filesize-bytes="0" data-filesize-percentage="100" rel="tag" title="Link to psychiatry/alcoholism tag index">alcoholism</a>, <a href="/doc/psychology/willpower/index" class="prefetch-not link-tag link-page link-annotated icon-not" data-filesize-bytes="0" data-filesize-percentage="100" rel="tag" title="Link to psychology/willpower tag index">willpower</a></span></p>
<blockquote>
<figure>
<img src="/doc/longevity/glp/psychology/2024-qeadan-gipandglp1dietdrugprotectiveeffectsonopioidandalcoholoverdose.jpg" title="Figure 1: Rate (95% CI) of incident substance-related outcomes ((a) opioid overdose; (b) alcohol intoxication) versus time since index encounter, for those prescribed any GIP/GLP-1 RA compared to those not prescribed, among those with a history of opioid use disorder and those with a history of alcohol use disorder." id="_-ssu4NFJ" class="float-right page-thumbnail invert-not outline" width="0" height="0"></img>
</figure>
<div class="page-description-annotation">
<p>Bibliography for directory <code>longevity/glp/psychology</code>, most recent first: 1 <a href="/doc/longevity/glp/psychology/index#see-alsos" id="_HbkZ2mwX" class="prefetch-not link-page icon-not">related tag</a>, 54 <a href="/doc/longevity/glp/psychology/index#links" id="_k47eskCR" class="prefetch-not link-page icon-not">annotations</a>, &amp; 7 <a href="/doc/longevity/glp/psychology/index#miscellaneous" id="_mLlXFPvg" class="prefetch-not link-page icon-not">links</a> (<a href="/doc/longevity/glp/index" class="prefetch-not link-page link-tag directory-indexes-upwards link-annotated" data-link-icon="arrow-up-left" data-link-icon-type="svg" rel="tag" title="Link to parent directory">parent</a>).</p>
</div>
<div class="columns TOC">
<ul>
<li><a href="/doc/longevity/glp/psychology/index#see-also" id="toc-see-also" class="prefetch-not link-page">See Also</a></li>
<li><a href="/doc/longevity/glp/psychology/index#links" id="toc-links" class="prefetch-not link-page">Links</a>
<ul>
<li><a href="/doc/longevity/glp/psychology/index#hristakeva-et-al-2025-section" id="toc-hristakeva-et-al-2025-section" class="prefetch-not link-page">“The No-Hunger Games: How GLP-1 Medication Adoption Is Changing Consumer Food Demand”, <span class="cite"><span class="cite-author-plural" title="et al">Hristakeva</span><span class="cite-joiner"> et al </span><span class="cite-date">2025</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#jiang-et-al-2025-section" id="toc-jiang-et-al-2025-section" class="prefetch-not link-page">“Brainstem GLP-1 Neurons Modulate Physiological Satiation and Drive Sustained Weight Loss in Obese Mice”, <span class="cite"><span class="cite-author-plural" title="et al">Jiang</span><span class="cite-joiner"> et al </span><span class="cite-date">2025</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#youmshajekian-2025-section" id="toc-youmshajekian-2025-section" class="prefetch-not link-page">“People on Ozempic Start Disliking Meat and Fried Foods; We’re Starting to Learn Why”, <span class="cite"><span class="cite-author">Youmshajekian</span><span class="cite-date">2025</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#dilley-et-al-2025-section" id="toc-dilley-et-al-2025-section" class="prefetch-not link-page">“Characteristics and Food Consumption for Current, Previous, and Potential Consumers of GLP-1s”, <span class="cite"><span class="cite-author-plural" title="et al">Dilley</span><span class="cite-joiner"> et al </span><span class="cite-date">2025</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#jerlhag-2025-section" id="toc-jerlhag-2025-section" class="prefetch-not link-page">“GLP-1 Receptor Agonists: Promising Therapeutic Targets for Alcohol Use Disorder”, <span class="cite"><span class="cite-author">Jerlhag</span><span class="cite-date">2025</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#giorgi-et-al-2025-section" id="toc-giorgi-et-al-2025-section" class="prefetch-not link-page">“An Analysis on the Role of Glucagon-Like Peptide-1 Receptor Agonists in Cognitive and Mental Health Disorders”, <span class="cite"><span class="cite-author-plural" title="et al">Giorgi</span><span class="cite-joiner"> et al </span><span class="cite-date">2025</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#mullin-2025-section" id="toc-mullin-2025-section" class="prefetch-not link-page">“Your Love Life on Ozempic: Beyond Treating Diabetes &amp; Helping People Lose Weight, GLP-1s May Also Improve Libido. But the Reasons Are As Complex As Desire Itself”, <span class="cite"><span class="cite-author">Mullin</span><span class="cite-date">2025</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#_54njOYyn-section" id="toc-_54njOYyn-section" class="prefetch-not link-page">“Weight Loss Drugs and Their Lesser Known Side Effects on Relationships”</a></li>
<li><a href="/doc/longevity/glp/psychology/index#_9PZy4YHP-section" id="toc-_9PZy4YHP-section" class="prefetch-not link-page">“Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.”</a></li>
<li><a href="/doc/longevity/glp/psychology/index#lähteenvuo-et-al-2024-section" id="toc-lähteenvuo-et-al-2024-section" class="prefetch-not link-page">“Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder”, <span class="cite"><span class="cite-author-plural" title="et al">Lähteenvuo</span><span class="cite-joiner"> et al </span><span class="cite-date">2024</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#qeadan-et-al-2024-2-section" id="toc-qeadan-et-al-2024-2-section" class="prefetch-not link-page">“The Association between Glucose-Dependent Insulinotropic Polypeptide And/or Glucagon-Like Peptide-1 Receptor Agonist Prescriptions and Substance-Related Outcomes in Patients With Opioid and Alcohol Use Disorders: A Real-World Data Analysis”, <span class="cite"><span class="cite-author-plural" title="et al">Qeadan</span><span class="cite-joiner"> et al </span><span class="cite-date">2024</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#qeadan-et-al-2024-1-section" id="toc-qeadan-et-al-2024-1-section" class="prefetch-not link-page">“The Association between Glucose-Dependent Insulinotropic Polypeptide And/or Glucagon-Like Peptide-1 Receptor Agonist Prescriptions and Substance-Related Outcomes in Patients With Opioid and Alcohol Use Disorders: A Real-World Data Analysis”, <span class="cite"><span class="cite-author-plural" title="et al">Qeadan</span><span class="cite-joiner"> et al </span><span class="cite-date">2024</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#chen-et-al-2024b-section" id="toc-chen-et-al-2024b-section" class="prefetch-not link-page">“GLP-1 Programs the Neurovascular Landscape”, <span class="cite"><span class="cite-author-plural" title="et al">Chen</span><span class="cite-joiner"> et al </span><span class="cite-date">2024b</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#_uA90efXF-section" id="toc-_uA90efXF-section" class="prefetch-not link-page">“Why Do Obesity Drugs Seem to Treat so Many Other Ailments?”</a></li>
<li><a href="/doc/longevity/glp/psychology/index#_8t--flDr-section" id="toc-_8t--flDr-section" class="prefetch-not link-page">“[The Hunger-Noise Monster]”</a></li>
<li><a href="/doc/longevity/glp/psychology/index#huang-et-al-2024-section" id="toc-huang-et-al-2024-section" class="prefetch-not link-page">“Dissociable Hindbrain GLP1R Circuits for Satiety and Aversion”, <span class="cite"><span class="cite-author-plural" title="et al">Huang</span><span class="cite-joiner"> et al </span><span class="cite-date">2024</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#arillotta-et-al-2024-section" id="toc-arillotta-et-al-2024-section" class="prefetch-not link-page">“Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach”, <span class="cite"><span class="cite-author-plural" title="et al">Arillotta</span><span class="cite-joiner"> et al </span><span class="cite-date">2024</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#levine-sedacca-2024-section" id="toc-levine-sedacca-2024-section" class="prefetch-not link-page">“NYC Law Student Addicted to Cheese Went to Nearly $6K-Per-Week Rehab”, <span class="cite"><span class="cite-author">Levine &amp; Sedacca</span><span class="cite-date">2024</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#baker-2024-section" id="toc-baker-2024-section" class="prefetch-not link-page">“They Promoted Body Positivity. Then They Lost Weight: Do Plus-Size Influencers Owe Their Followers an Explanation When Their Bodies Change?”, <span class="cite"><span class="cite-author">Baker</span><span class="cite-date">2024</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#richards-et-al-2023-section" id="toc-richards-et-al-2023-section" class="prefetch-not link-page">“Substantial Decrease in Alcohol Use Disorder Symptoms Secondary to Semaglutide Therapy for Weight Loss: A Case Series”, <span class="cite"><span class="cite-author-plural" title="et al">Richards</span><span class="cite-joiner"> et al </span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#wickman-2023-section" id="toc-wickman-2023-section" class="prefetch-not link-page">“Sharon Osbourne Quit Ozempic Because She’s ‘Too Skinny’”, <span class="cite"><span class="cite-author">Wickman</span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#lagou-et-al-2023-section" id="toc-lagou-et-al-2023-section" class="prefetch-not link-page">“GWAS of Random Glucose in 476,326 Individuals Provide Insights into Diabetes Pathophysiology, Complications and Treatment Stratification”, <span class="cite"><span class="cite-author-plural" title="et al">Lagou</span><span class="cite-joiner"> et al </span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#blum-2023-section" id="toc-blum-2023-section" class="prefetch-not link-page">“People on Drugs Like Ozempic Say Their ‘Food Noise’ Has Disappeared: For Some, It’s a Startling Side Effect”, <span class="cite"><span class="cite-author">Blum</span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#galen-et-al-2023-section" id="toc-galen-et-al-2023-section" class="prefetch-not link-page">“Brain Responses to Nutrients Are Severely Impaired and Not Reversed by Weight Loss in Humans With Obesity: a Randomized Crossover Study”, <span class="cite"><span class="cite-author-plural" title="et al">Galen</span><span class="cite-joiner"> et al </span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#reynolds-2023-section" id="toc-reynolds-2023-section" class="prefetch-not link-page">“What the Scientists Who Pioneered Weight-Loss Drugs Want You to Know”, <span class="cite"><span class="cite-author">Reynolds</span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#marcus-2023-section" id="toc-marcus-2023-section" class="prefetch-not link-page">“I Lost 40 Pounds on Ozempic. But I’m Left With Even More Questions.”, <span class="cite"><span class="cite-author">Marcus</span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#zhang-2023-1-section" id="toc-zhang-2023-1-section" class="prefetch-not link-page">“Ozempic’s Next Act: People Taking the Drug for Weight Loss Say They Have Also Stopped Drinking, Smoking, Shopping, and Even Nail-Biting”, <span class="cite"><span class="cite-author">Zhang</span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#seo-et-al-2023b-section" id="toc-seo-et-al-2023b-section" class="prefetch-not link-page">“Effects of Liraglutide on Depressive Behavior in a Mouse Depression Model and Cognition in the Probe Trial of Morris Water Maze Test”, <span class="cite"><span class="cite-author-plural" title="et al">Seo</span><span class="cite-joiner"> et al </span><span class="cite-date">2023b</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#yammine-et-al-2023-section" id="toc-yammine-et-al-2023-section" class="prefetch-not link-page">“Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series Study”, <span class="cite"><span class="cite-author-plural" title="et al">Yammine</span><span class="cite-joiner"> et al </span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#aranäs-et-al-2023-section" id="toc-aranäs-et-al-2023-section" class="prefetch-not link-page">“Semaglutide Reduces Alcohol Intake and Relapse-Like Drinking in Male and Female Rats”, <span class="cite"><span class="cite-author-plural" title="et al">Aranäs</span><span class="cite-joiner"> et al </span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#battini-et-al-2023-section" id="toc-battini-et-al-2023-section" class="prefetch-not link-page">“The Potential Antidepressant Effect of Antidiabetic Agents: New Insights from a Pharmacovigilance Study Based on Data from the Reporting System Databases FAERS and VigiBase”, <span class="cite"><span class="cite-author-plural" title="et al">Battini</span><span class="cite-joiner"> et al </span><span class="cite-date">2023</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#bhalla-et-al-2022-section" id="toc-bhalla-et-al-2022-section" class="prefetch-not link-page">“Protective Role of IGF-1 and GLP-1 Signaling Activation in Neurological Dysfunctions”, <span class="cite"><span class="cite-author-plural" title="et al">Bhalla</span><span class="cite-joiner"> et al </span><span class="cite-date">2022</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#evans-et-al-2022-section" id="toc-evans-et-al-2022-section" class="prefetch-not link-page">“Dose Titration With the Glucagon-Like Peptide-1 Agonist, Liraglutide, Reduces Cue- and Drug-Induced Heroin Seeking in High Drug-Taking Rats”, <span class="cite"><span class="cite-author-plural" title="et al">Evans</span><span class="cite-joiner"> et al </span><span class="cite-date">2022</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#yang-et-al-2022-2-section" id="toc-yang-et-al-2022-2-section" class="prefetch-not link-page">“Glucagon-Like Peptide 1 Receptor Activation Inhibits Microglial Pyroptosis via Promoting Mitophagy to Alleviate Depression-Like Behaviors in Diabetic Mice”, <span class="cite"><span class="cite-author-plural" title="et al">Yang</span><span class="cite-joiner"> et al </span><span class="cite-date">2022</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#flintoff-et-al-2021-section" id="toc-flintoff-et-al-2021-section" class="prefetch-not link-page">“Treating Cognitive Impairment in Schizophrenia With GLP-1RAs: an Overview of Their Therapeutic Potential”, <span class="cite"><span class="cite-author-plural" title="et al">Flintoff</span><span class="cite-joiner"> et al </span><span class="cite-date">2021</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#angarita-et-al-2021-section" id="toc-angarita-et-al-2021-section" class="prefetch-not link-page">“Testing the Effects of the GLP-1 Receptor Agonist Exenatide on Cocaine Self-Administration and Subjective Responses in Humans With Cocaine Use Disorder”, <span class="cite"><span class="cite-author-plural" title="et al">Angarita</span><span class="cite-joiner"> et al </span><span class="cite-date">2021</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#zhang-et-al-2020-01-section" id="toc-zhang-et-al-2020-01-section" class="prefetch-not link-page">“Activation of GLP-1 Receptors Attenuates Oxycodone Taking and Seeking without Compromising the Antinociceptive Effects of Oxycodone in Rats”, <span class="cite"><span class="cite-author-plural" title="et al">Zhang</span><span class="cite-joiner"> et al </span><span class="cite-date">2020</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#fortin-et-al-2020-section" id="toc-fortin-et-al-2020-section" class="prefetch-not link-page">“GABA Neurons in the Nucleus Tractus Solitarius Express GLP-1 Receptors and Mediate Anorectic Effects of Liraglutide in Rats”, <span class="cite"><span class="cite-author-plural" title="et al">Fortin</span><span class="cite-joiner"> et al </span><span class="cite-date">2020</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#vallöf-et-al-2019-section" id="toc-vallöf-et-al-2019-section" class="prefetch-not link-page">“Glucagon-Like Peptide-1 Receptors within the Nucleus of the Solitary Tract Regulate Alcohol-Mediated Behaviors in Rodents”, <span class="cite"><span class="cite-author-plural" title="et al">Vallöf</span><span class="cite-joiner"> et al </span><span class="cite-date">2019</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#thomsen-et-al-2019-section" id="toc-thomsen-et-al-2019-section" class="prefetch-not link-page">“Effects of Glucagon-Like Peptide 1 Analogs on Alcohol Intake in Alcohol-Preferring Vervet Monkeys”, <span class="cite"><span class="cite-author-plural" title="et al">Thomsen</span><span class="cite-joiner"> et al </span><span class="cite-date">2019</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#farr-et-al-2019-section" id="toc-farr-et-al-2019-section" class="prefetch-not link-page">“Longer-Term Liraglutide Administration at the Highest Dose Approved for Obesity Increases Reward-Related Orbitofrontal Cortex Activation in Response to Food Cues: Implications for Plateauing Weight Loss in Response to Anti-Obesity Therapies”, <span class="cite"><span class="cite-author-plural" title="et al">Farr</span><span class="cite-joiner"> et al </span><span class="cite-date">2019</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#siskind-et-al-2018-section" id="toc-siskind-et-al-2018-section" class="prefetch-not link-page">“Glucagon-Like Peptide-1 Receptor Agonists for Antipsychotic-Associated Cardio-Metabolic Risk Factors: A Systematic Review and Individual Participant Data Meta-Analysis”, <span class="cite"><span class="cite-author-plural" title="et al">Siskind</span><span class="cite-joiner"> et al </span><span class="cite-date">2018</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#camkurt-et-al-2018-section" id="toc-camkurt-et-al-2018-section" class="prefetch-not link-page">“Liraglutide for Psychiatric Disorders: Clinical Evidence and Challenges”, <span class="cite"><span class="cite-author-plural" title="et al">Camkurt</span><span class="cite-joiner"> et al </span><span class="cite-date">2018</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#mansur-et-al-2018-section" id="toc-mansur-et-al-2018-section" class="prefetch-not link-page">“Cognitive Dysfunction and Metabolic Comorbidities in Mood Disorders: A Repurposing Opportunity for Glucagon-Like Peptide 1 Receptor Agonists?”, <span class="cite"><span class="cite-author-plural" title="et al">Mansur</span><span class="cite-joiner"> et al </span><span class="cite-date">2018</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#hernandez-et-al-2018-section" id="toc-hernandez-et-al-2018-section" class="prefetch-not link-page">“Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Attenuates Cocaine Seeking in Rats”, <span class="cite"><span class="cite-author-plural" title="et al">Hernandez</span><span class="cite-joiner"> et al </span><span class="cite-date">2018</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#ishøy-et-al-2017-section" id="toc-ishøy-et-al-2017-section" class="prefetch-not link-page">“No Cognitive-Enhancing Effect of GLP-1 Receptor Agonism in Antipsychotic-Treated, Obese Patients With Schizophrenia”, <span class="cite"><span class="cite-author-plural" title="et al">Ishøy</span><span class="cite-joiner"> et al </span><span class="cite-date">2017</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#sirohi-et-al-2016-section" id="toc-sirohi-et-al-2016-section" class="prefetch-not link-page">“Central &amp; Peripheral Glucagon-Like Peptide-1 Receptor Signaling Differentially Regulate Addictive Behaviors”, <span class="cite"><span class="cite-author-plural" title="et al">Sirohi</span><span class="cite-joiner"> et al </span><span class="cite-date">2016</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#sharma-et-al-2014-section" id="toc-sharma-et-al-2014-section" class="prefetch-not link-page">“Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Prevents Development of Tolerance to Anti-Anxiety Effect of Ethanol and Withdrawal-Induced Anxiety in Rats”, <span class="cite"><span class="cite-author-plural" title="et al">Sharma</span><span class="cite-joiner"> et al </span><span class="cite-date">2014</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#sisley-et-al-2014-section" id="toc-sisley-et-al-2014-section" class="prefetch-not link-page">“Neuronal GLP1R Mediates Liraglutide’s Anorectic but Not Glucose-Lowering Effect”, <span class="cite"><span class="cite-author-plural" title="et al">Sisley</span><span class="cite-joiner"> et al </span><span class="cite-date">2014</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#jelsing-et-al-2012-section" id="toc-jelsing-et-al-2012-section" class="prefetch-not link-page">“Liraglutide: Short-Lived Effect on Gastric Emptying—Long Lasting Effects on Body Weight”, <span class="cite"><span class="cite-author-plural" title="et al">Jelsing</span><span class="cite-joiner"> et al </span><span class="cite-date">2012</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#hunter-hölscher-2012-section" id="toc-hunter-hölscher-2012-section" class="prefetch-not link-page">“Drugs Developed to Treat Diabetes, Liraglutide and Lixisenatide, Cross the Blood Brain Barrier and Enhance Neurogenesis”, Hunter &amp; <span class="cite"><span class="cite-author">Hölscher</span><span class="cite-date">2012</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#kanoski-et-al-2011-section" id="toc-kanoski-et-al-2011-section" class="prefetch-not link-page">“Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4”, <span class="cite"><span class="cite-author-plural" title="et al">Kanoski</span><span class="cite-joiner"> et al </span><span class="cite-date">2011</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#madsen-et-al-1995-section" id="toc-madsen-et-al-1995-section" class="prefetch-not link-page">“Transplantable Glucagonomas Derived from Pluripotent Rat Islet Tumor Tissue Cause Severe Anorexia and Adipsia”, <span class="cite"><span class="cite-author-plural" title="et al">Madsen</span><span class="cite-joiner"> et al </span><span class="cite-date">1995</span></span></a></li>
<li><a href="/doc/longevity/glp/psychology/index#_0TASkT-r-section" id="toc-_0TASkT-r-section" class="prefetch-not link-page">“Lotte Bjerre Knudsen: The Scientist Who Drove GLP-1 Drugs For Obesity and Alzheimer’s”</a></li>
<li><a href="/doc/longevity/glp/psychology/index#sort-by-magic" id="toc-sort-by-magic" class="prefetch-not link-page">Sort By Magic</a>
<ul>
<li><a href="/doc/longevity/glp/psychology/index#metabolic-therapy-neuropharmacology-food-demand-psychological-impact-obesity-research" id="toc-metabolic-therapy-neuropharmacology-food-demand-psychological-impact-obesity-research" class="prefetch-not link-page"><code>metabolic-therapy neuropharmacology food-demand psychological-impact obesity-research</code></a></li>
<li><a href="/doc/longevity/glp/psychology/index#weight-loss" id="toc-weight-loss" class="prefetch-not link-page"><code>weight-loss</code></a></li>
<li><a href="/doc/longevity/glp/psychology/index#substance-use-therapy" id="toc-substance-use-therapy" class="prefetch-not link-page"><code>substance-use-therapy</code></a></li>
<li><a href="/doc/longevity/glp/psychology/index#glp-1-therapeutics" id="toc-glp-1-therapeutics" class="prefetch-not link-page"><code>glp-1-therapeutics</code></a></li>
</ul></li>
<li><a href="/doc/longevity/glp/psychology/index#titled-links-wikipedia" id="toc-titled-links-wikipedia" class="prefetch-not link-page">Wikipedia (3)</a></li>
</ul></li>
<li><a href="/doc/longevity/glp/psychology/index#miscellaneous" id="toc-miscellaneous" class="prefetch-not link-page">Miscellaneous</a></li>
<li><a href="/doc/longevity/glp/psychology/index#link-bibliography-section" id="toc-link-bibliography-section" class="prefetch-not link-page">Bibliography</a></li>
</ul>
</div>
</blockquote>